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Abstract
Objective: Inflammation is a suggested mediator in pancreatic carcinogenesis. Severe acne may
be a proxy of inflammation; however, the association between severe acne with pancreatic
cancer is unstudied. Here, we explored the association between self-reported severe acne and
pancreatic cancer risk for the purpose of hypothesis generation.
Methods: In a hospital-based case-control study, we used information from personal interviews
with 939 confirmed cases of pancreatic adenocarcinoma and 440 controls to assess history of
teenage and adult acne. We evaluated the association between severe acne and pancreatic cancer
risk by estimating adjusted odds ratios (ORs) and 95% confidence intervals (CIs) using
multivariable logistic regression.
Results: After adjusting for age, race, sex, recent body mass index, education, and diabetes, any
history of severe acne was not significantly associated with pancreatic cancer risk (adjusted OR
ever vs. never=1.42, 95% CI: 0.65, 3.09). Similarly, there were no statistically significant
associations with pancreatic cancer risk when specifically examining teenage severe acne
(OR=1.60, 95% CI: 0.67, 3.80), adult severe acne (OR=1.23, 95% CI: 0.32, 4.76), or cystic acne
(OR=1.37, 95% CI: 0.71, 2.67).
Conclusion: We did not observe statistically significant associations between severe acne and
risk of pancreatic cancer. The low prevalence of severe acne in this population limited our ability
to detect modest associations. Observed magnitudes of association suggest a possible positive
association that warrants follow-up in larger studies.
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Introduction
Pancreatic cancer is a deadly disease that currently has poor prognosis. There were
56,770 estimated new cases in 2019 (3.2% of all new cancer cases) and resulted in 45,750
estimated deaths in 2019 (7.5% of all cancer deaths).1 In fact, a study published in 2011 reported
a 5-year survival rate of 1.3%.2 The pancreas is an organ that aids digestion and produces
hormones that help manage and regulate blood sugar. Both cancerous and noncancerous tumors
can occur in the pancreas but the most common type of cancer that forms starts in the cells that
line the ducts that carry the digestive enzymes and ductular fluid and bicarbonate out of the
pancreas, known as pancreatic ductal adenocarcinoma (PDAC).3 Unfortunately, pancreatic
cancer is hard to detect at its early stages when it is most treatable. This is partially a result of
there being close to no symptoms until the cancer has spread to the other organs.4 Since
pancreatic cancer often presents at an advanced stage, it is ranked among cancers as last in terms
of prognostic outcomes for patients (with 5-year survival rates between 2-9%).5
Research fueled by curiosity around the disease and its low survival rate has highlighted
inflammation as a hypothesized mediator of pancreatic cancer development.6 Other risk factors
include smoking, diabetes, family history, obesity, and old age. Although further research is
needed to determine the exact mechanisms through which inflammation contributes to tumor
initiation and development, pancreatitis is a strong risk factor.7 A growing body of evidence also
supports inflammation playing a role at all stages of acne development (contrary to the
conventional perspective that Propionibacterium acnes colonizes a sebaceous follicle duct,
causing an inflammatory immune response).8 Instead of focusing on inflammation’s secondary
role in the development of acne, more research has emphasized its primary role (the idea that
inflammation triggers the process). New research shows that systemic inflammation, which can
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be caused by stress, poor diet, and other environmental factors, can cause normal levels of sebum
in follicles to “oxidize.”9 Therefore, inflammation can contribute to lowering the oxygen content
of the sebum which provides an optimal environment for Propionibacterium acnes to grow.
Given this, we hypothesize that severe acne may serve as a proxy of underlying inflammatory
processes and could thus be associated with increased pancreatic cancer risk. Additionally,
studies have found that androgens can affect acne severity; these androgens may generate
inflammatory processes as well.10 11 Schooling’s study argued that androgens in men, for
example, may be a factor in generating rather than protecting against inflammation by
suppressing the immune system.12
Prior epidemiologic studies suggest acne may play a role in cancer risk. In the Nurses’
Health Study II, for instance, women who reported a history of severe acne as a teenager were
44% more likely to develop melanoma and 17% more likely to develop breast cancer than those
with mild or no acne.13 In addition, a meta-analysis of eight studies evaluating the association
between acne and prostate cancer risk reported a 1.5-fold increased risk for acne in cohort studies
(OR=1.51, 95% CI 1.19-1.93), but no association in case-control studies.14
There currently have been no studies evaluating the potential association between severe
acne (diagnosed in teenage years and in adulthood) and pancreatic cancer risk specifically. The
objective of this thesis is to explore if self-reported severe acne is associated with increased
pancreatic cancer risk for the purpose of hypothesis generation. This association is of particular
interest since it has not been looked at before and acne may be an indicator of inflammation.
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Methods
Study Population
This hospital-based case-control study was conducted at Memorial Sloan Kettering
Cancer Center (MSKCC) within the Pancreatic Tumor Registry, established in 2002. As detailed
previously, eligible cases were defined as those with pathologically or cytologically confirmed
pancreatic adenocarcinoma and who spoke English.1516 Cases were identified upon initial
consultation and diagnosis, follow-up after surgery, or receipt of chemotherapy. Of approached
potential cases, 13% were ineligible (primarily because they did not speak English); of eligible
cases, 79% consented to participate. Eligible controls had no personal history of cancer other
than non-melanoma skin cancer and who also spoke English. Controls were identified from
individuals who accompanied patients to clinics at Memorial Sloan Kettering Cancer Center,
other than clinics where patients with pancreatic cancer or intraductal papillary mucinous
neoplasms were seen (N=265), or from spouses of patients with pancreatic cancer (N=175). Of
approached potential controls, 15% were ineligible (primarily because of history of cancer); of
eligible controls, 59% consented to participate. Eligible individuals filled out questionnaires and
provided biospecimens. Epidemiologic (family history, sociodemographics, lifestyle), clinical
(tumor characteristics, treatment), and biological (blood and saliva) components were collected.
This study was also reviewed by the institutional review board at MSKCC.
For this analysis, we excluded 6 controls who had personal histories of cancer other than
non-melanoma skin cancer. We also excluded 11 individuals who did not fill out any of the
variables regarding whether or not they had had acne as a teenager or as an adult (categorized as
individuals in their twenties) and the severity of said acne. This resulted in a final study sample
of 939 cases and 440 controls.
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Variables of Interest
Data on self-reported occurrence of acne and subsequent severity in teenage and adult
years were of interest as well as the occurrence of cystic acne. An “ever acne” variable was also
created by positive history of acne either in teenage or adult years. Other baseline characteristics
and variables of interest such as age, gender, recent body mass index (BMI), smoking status,
histories of pancreatitis, alcohol use and diabetes diagnosis, race/ethnicity, and attained
education level were assessed. Whether or not the patient had undergone a hysterectomy,
oophorectomy, and whether or not the patient was taking birth control or menopausal hormonal
medication was also recorded.
For determining history of acne, the questionnaire contained the following questions:
“When you were a teenager, did you have acne?” and “If yes, was your acne mild, moderate, or
severe?” Other questions included “When you were in your twenties and thirties, did you have
acne?” and “If yes, would you say your acne in your twenties was mild, moderate, or severe?”
and “Sometimes people who have acne in their twenties or thirties have cystic acne, which has
large painful solid lumps under the skin. Did you have this kind of acne?”
Statistical Analysis
We computed baseline characteristics for the 939 cases and 440 controls. BMI was
evaluated in both continuous and categorical form (<18.5, 18.5-24.9, 25-29.9, 30-34.9, >35
kg/m2). Analyses were run in SAS and logistic regression models were used to estimate the odds
ratios (ORs) and 95% confidence intervals (95% CIs) for the association of pancreatic cancer
with the a priori variables history of severe acne, severe teenage acne, severe adult acne, and
cystic acne. We used a minimally adjusted model including age, race, and sex. We also defined a
“fully” adjusted model using a backwards variable elimination technique to evaluate the
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inclusion of variables in Table 1. The final fully adjusted model included age (continuous), race
(white, other), sex, BMI (continuous), education (<12 years, 12 years, 12-16 years, or >16
years), and diabetes status (yes, no). To address missing covariate data, we used the missing
indicator approach to address missing BMI information. Missing birth control data were assigned
a single separate category to represent missingness. Because the frequency of missing data for
remaining variables was low, missing race was assigned to white, and missing hysterectomy,
oophorectomy, menopausal hormone, and pancreatitis data were assigned to the “No” category.
We also calculated p for trend for severity of teenage acne and severity of adult acne by
modeling the categories (mild/none, moderate, severe) as an ordinal variable. We used α=0.05 to
determine nominal statistical significance.
We explored interactions by stratifying associations by age (<=50, >50 years) and sex.
We examined heterogeneity using likelihood ratio statistics comparing nested models with and
without multiplicative interaction terms between sex and acne variables and age and acne
variables. We conducted additional sensitivity analyses to assess the influence of excluding
spouse controls (N=175), those with alcoholism (N=22), those with pancreatitis (N=117), and
cases who had another cancer in addition to pancreatic (besides basal cell non-melanoma cancer)
(N=178). The number of individuals with alcoholism was assessed through the questionnaire
which explicitly asked the participants whether or not they had “ever had alcoholism” and if so,
the “age when diagnosed.”
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Results
Baseline Characteristics
Table 1 shows the baseline characteristics of the 939 cases and 440 controls. Within the
939 cases, 34 individuals reported ever having severe acne (3.6%) and of the 440 controls, 10
individuals reported ever having severe acne (2.3%). Among those that had had teenage acne, the
majority for both cases and controls classified their acne as mild (86.1% and 86.8%)
respectively. Both cases and controls who had had adult acne also mostly classified their acne as
mild (96.2% and 95.5%) respectively. Most of the participants did not have cystic acne (96.5%
for cases and 96.6% for controls). The mean ages of the cases (63.92) and controls (59.91) were
similar, with the majority of participants of white race (89.4% of cases and 88.2% of controls).
Cases had lower recent BMI (mean=23.7 kg/m2) compared to controls (mean=26.0 kg/m2)
(p=3.55 × 10'() ). Cases also completed fewer years of schooling compared to controls
(p=1.14 × 10'+ ), were less likely to be taking menopausal hormones (p=0.02), more likely to
have diabetes (p=3.45 × 10'(, ), and more likely to have pancreatitis (p=1.78 × 10'(/ ). The
remaining characteristics were similar between cases and controls (Table 1).
Acne Variables
We did not observe a statistically significant association between history of severe acne
at any age and risk of pancreatic cancer (fully-adjusted OR=1.42, 95% CI: 0.65, 3.09) compared
to the reference category (none or mild acne). (Table 2). Similarly, compared to subjects
reporting mild or no acne, a statistically significant association was not observed for subjects
reporting severe teenage acne (fully-adjusted OR=1.60, 95% CI: 0.67, 3.80, p-trend=0.13),
severe adult acne (fully-adjusted OR=1.23, 95% CI: 0.32, 4.76, p-trend=0.99), and cystic acne
(fully-adjusted OR=1.37, 95% CI: 0.71, 2.67).
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When stratified by sex, there was some indication that the association with history of
severe acne may be stronger in men; however, p values for heterogeneity were not statistically
significant for any of the acne variables (Table 3). Similarly, there were no statistically
significant differences when stratified by age and the p values for heterogeneity were not
statistically significant for any of the acne variables (Table 4). In additional sensitivity analyses,
we did not observe appreciable differences in the interpretation of our results when excluding
spousal controls, cases who had more than just pancreatic cancer (excluding those with basal cell
non-melanoma skin cancer), or individuals with histories of alcoholism or pancreatitis.
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Discussion
In this study, we did not observe a statistically significant association between “ever
severe” acne and pancreatic cancer. This was also true of the associations between severe
teenage and adult acne and cystic acne and pancreatic cancer risk. Therefore, it cannot be
concluded that severe acne increases risk for pancreatic cancer in this study. Further, we did not
observe evidence of significant interactions by age or sex.
Our “ever severe” minimally adjusted OR=1.67 and adjusted OR=1.42 and although this
magnitude of association is consistent with previously published ORs for acne and cancer risk at
other cancer sites, only 44 individuals out of the 1379 in the study sample (3.19%) reported ever
having severe acne. Therefore, even though there were many cases in the study, we had limited
statistical power to detect more modest associations. However, the magnitudes of association
themselves are consistent with those previously published. Platz et al. looked at acne and risk of
prostate cancer and found a multivariable-adjusted relative risk (RR) of 1.70 with a 95% CI of
1.03, 2.80.17 Additionally, Zhang et al. found that a significant association was observed in metaanalysis between acne in adolescence and prostate cancer risk within the cohort studies with an
OR of 1.51 and 95% CI of 1.19-1.93.18 Murphy et al. utilized data from the Sister Study, a large
prospective cohort of women who had sisters diagnosed with breast cancer but were cancer free
themselves. They found that a diagnosis of having severe acne was associated with having a
higher risk of breast cancer (HR 1.23) especially in women diagnosed with severe acne before
the age of 18 (HR 1.40).19 Another study hypothesized that acne may predict risk of hormonerelated cancers. Hazard ratios were estimated for cancers of the breast, thyroid, large bowel and
rectum (colorectal), ovary, cervix, endometrium, skin (melanoma), and lymphocytes (nonHodgkin lymphoma) for women who had had severe teen acne. After adjustment for previously
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known risk factors of each cancer, among women with a history of severe teenage acne, the
hazard ratio was increased (multivariable-adjusted HR=1.44, 95% CI 1.03-2.01) for melanoma,
and for breast cancer (HR=1.17, 95% CI 1.03-1.32).20 By analogy, there could also be
associations between severe acne and pancreatic cancer risk; this cancer site was not addressed in
the eight-site study. Further studies with larger numbers of participants with severe acne are
needed.
There are a few limitations with the present study including the aforementioned power
and sample size and the fact that acne was self-reported by participants. Self-reported data can be
unreliable especially since severity of acne can be subjective. In the future, studies could include
pictures for subjects to choose from that would best represent the severity of acne they
experienced. This would allow for a more objective determination. Additionally, since the data
were collected after diagnosis, there is a chance of recall bias as well. Most of the study
participants were in their 60’s and details about teenage and adult acne could be difficult to
remember and contribute to information that is not sufficiently accurate. Hospital-based controls
are also not ideal, though perhaps may mitigate some degree of recall bias because of their
involvement with patients at the hospital. Since for this tertiary care institution there is no clearly
defined population from which cases emerge, using hospital-based controls allowed us to enroll
individuals who are likely to be similar in background characteristics to the cases. However,
more future population-based studies are needed.
It is also important to note that although the latency of pancreatic cancer is long and acne
usually occurs earlier in life, it is still worth exploring early life exposures since no prior research
has been performed in this specific area. Since there are interesting mechanisms in play related to
both acne and pancreatic cancer risk like inflammation, this study design is appropriate for the
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purpose of hypothesis generation. Although our results were not statistically significant, it is
possibly a function of the small sample size. Our observed associations have similar magnitudes
to ones in prior studies which suggests that this question warrants further research in larger
studies. In the future, other studies could focus on acquiring more individuals who have severe
acne (obtained through means other than self-report) to study what may be smaller associations.
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